Approva generates a personalized, clinically precise appeal letter in minutes — for Ozempic, Wegovy, Mounjaro, and Zepbound. No lawyers. No confusing paperwork. Just results.
No spam. Early users get 50% off at launch.
65%+
of appeals succeed with proper documentation
88%
of patients never challenge their denial
$12,000
average annual savings when coverage is approved
Every year, millions of Americans are denied coverage for GLP-1 medications. Insurers claim the use is “cosmetic” or “not medically necessary” — even with a valid prescription for diabetes or obesity.
The problem is that most patients don't know they can fight back. And those who try often give up at the first sign of paperwork.
Federal law guarantees your right to appeal. With the right documentation, the majority of cases are resolved without ever going to court.
Answer 8 quick questions: which medication was denied, why, your diagnoses, and your insurance plan. No medical jargon — we guide you through it.
Our AI builds a personalized letter that directly counters your insurer's specific denial reason — citing FDA guidelines, clinical evidence, and your personal health history.
Download your letter in PDF, follow our step-by-step checklist, and submit. We show you exactly who to send it to, by when, and what to expect.
“I had no idea I could fight back. My doctor's appeal was denied 4 times. With the right letter, it was approved in 11 days.”
— Sarah M., Zepbound user, Texas
“Considering the cost of the drug vs. the appeal service, it's a complete no-brainer. I wish I'd done this sooner.”
— James R., Wegovy user, Ohio
“My doctor didn't even try to appeal when Zepbound was first denied. Finding this changed everything.”
— Michelle T., Mounjaro user, California
Your insurance counted on you giving up. Join the early access list and be first to fight back.
No spam. Early users get 50% off at launch.